Full name
BIOSELAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
26.40.Z - Manufacture of electronic consumer products
46.90.Z - Non-specialized wholesale trade
62.01.Z - Activities related to programming, IT consulting, and related activities
70.22.Z - Head office activities and management consultancy
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
96.09.Z - Individual service activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -0 | -0,2 | -0 | 100 |
EBITDA | 0 | -0,2 | 0 | 101,3 |
Short time liabilities | 0,1 | 0,1 | 0,1 | 8,9 |
Equity capital | 0,2 | -0 | -0 | -0,3 |
Operating profit (EBIT) | -0 | -0,2 | 0 | 101,3 |
Assets | 1,1 | 0 | 0 | 18,3 |
Net profit (loss) | -0 | -0,2 | -0 | 100 |
Cash | 0,2 | 0 | 0 | -61,1 |
Net income from sale | 0,8 | 0,2 | 0 | -87 |
Liabilities and provisions for liabilities | 0,9 | 0,1 | 0,1 | 8,9 |
Working assets | 1,1 | 0 | 0 | 18,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -0,9 | 735,7 | 0,3 | -735,4 |
Equity capital to total assets | 18,6 | -108,5 | -91,9 | 16,6 |
Gross profit margin | -0,2 | -100,9 | -0,3 | 100,6 |
EBITDA Margin | 0,4 | -100,4 | 10,3 | 110,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 96 | 806 | 710 |
Current financial liquidity indicator | 1.2279642820358276 | 0.479726642370224 | 0.5210995674133301 | 0 |
Net dept to EBITDA | -81.2755355834961 | -0.18048523366451263 | 16.998252868652344 | 17,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane